Gottfried Konecny
戈特弗里德·科内奇
MD
Professor of Medicine; Director, Gynecologic Oncology Research Program医学教授，妇科肿瘤研究计划主任
👥Biography 个人简介
Gottfried Konecny is a leading molecular oncologist at UCLA focused on HER2 amplification and targeted therapy in endometrial cancer. His translational research bridges molecular biology and clinical trials to develop more effective precision therapies for gynecologic malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
HER2 Targeting in Endometrial Cancer
Characterized HER2 amplification in endometrial cancer and led early clinical trials evaluating trastuzumab-based regimens, establishing HER2 as an actionable target in uterine serous carcinoma.
Genomic Classification of Endometrial Cancer
Applied comprehensive molecular profiling to endometrial cancer subtypes, contributing to prognostic stratification and identification of targetable alterations guiding precision oncology approaches.
Representative Works 代表性著作
Amplification of HER-2/neu in Uterine Serous Carcinoma
Cancer Research (2009)
Established HER2 amplification as a frequent and clinically significant event in uterine serous carcinoma, motivating targeted therapy development.
Phase II Trial of Ado-Trastuzumab Emtansine for HER2-Positive Uterine Serous Carcinoma
Journal of Clinical Oncology (2021)
Demonstrated efficacy of T-DM1 antibody-drug conjugate in HER2-positive uterine serous carcinoma, expanding targeted therapy options.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bradley J. Monk
University of Arizona / HonorHealth
Kathleen N. Moore
Stephenson Cancer Center, University of Oklahoma
Ana Oaknin
Vall d'Hebron University Hospital
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center
关注 戈特弗里德·科内奇 的研究动态
Follow Gottfried Konecny's research updates
留下邮箱，当我们发布与 Gottfried Konecny（UCLA David Geffen School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment